Primary Site >> Stomach Cancer
Gene >> ARL6IP5
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Identification and functional characterization of JWA polymorphisms and their association with risk of gastric cancer and esophageal squamous cell carcinoma in a Chinese population. PMID: 17479402 |
Ref: Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer. PMID: 22452940 Ref: Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer. PMID: 23285001 |
Ref: High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients. PMID: 23307041 Ref: MDM2 is a useful prognostic biomarker for resectable gastric cancer. PMID: 23347235 |
Ref: JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells. PMID: 25476899 |
Ref: JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a high-risk subgroup of HER2-positive gastric carcinoma patients. PMID: 27167206 Ref: JWA down-regulates HER2 expression via c-Cbl and induces lapatinib resistance in human gastric cancer cells. PMID: 27708243 |
Ref: JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells. PMID: 28671676 |
Ref: RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis. PMID: 29481911 Ref: JWA suppresses the invasion of human breast carcinoma cells by downregulating the expression of CXCR4. PMID: 29658570 |